Latest Going Concern News

Jayride Group Limited reports a reduced quarterly loss and secures fresh capital, yet faces ongoing uncertainty over its ability to continue as a going concern during its ASX reinstatement process.

Advanced Innergy Holdings Ltd (AIH) has delivered strong audited FY25 financial results, marked by solid revenue growth, improved profitability, and strategic acquisitions, while confirming FY26 guidance and debuting on the ASX.

Epsilon Healthcare reported a 19% revenue increase to $3.4 million for the half year ended June 2025, driven by new client wins and its pharmacy segment launch. However, net losses widened 44% to $2.07 million, reflecting administration and financing costs during its recovery phase.

Alexium International Group Limited has announced a pro rata non-renounceable rights issue to raise approximately AUD 6.77 million, primarily to repay shareholder loans and finance the acquisition of Microtek Laboratories' microencapsulation business.

Minbos Resources has launched a prospectus offering nearly 118 million free attaching options to recent Placement investors, aiming to bolster funding for its Cabinda fertilizer plant amid operational and geopolitical challenges in Angola.

ActivePort Group Ltd is launching a pro-rata bonus option offer, granting shareholders 1 option per 5 shares held, exercisable at $0.04 and expiring in 2028. While no immediate funds will be raised, full exercise could inject over $9 million into the company.

Alvo Minerals Limited has issued a small, invitation-only share offer to remove trading restrictions on recently issued shares, while highlighting ongoing funding and operational risks tied to its Brazilian copper-zinc projects.

Findi Limited reported a 51% surge in revenue to $49.26 million for the half year ended 30 September 2025, driven by key acquisitions in India. However, the company posted a significant operating loss of $24.65 million amid integration costs and faces material uncertainty over its going concern status.

Metro Performance Glass Limited has returned to profitability in the first half of 2025, posting a NZD 4.5 million profit before tax and significantly reducing its debt through a NZD 23.9 million equity raise.

Nufarm Finance (NZ) Limited reported a modest 1.1% rise in net profit to $20.53 million for the year ended September 2025, alongside increased distributions to security holders and maintained strong liquidity backed by its parent company.

Biotron Limited has launched a $1.5 million non-renounceable rights issue to fund its strategic acquisition of Sedarex Limited and support ongoing drug development programs. The capital raise follows shareholder approval and aims to diversify Biotron’s portfolio with a next-generation general anaesthetic.

Genmin Limited has launched a A$25.7 million equity raising to advance its Baniaka iron ore project in Gabon, aiming for a final investment decision by mid-2026. The raise includes strategic collaboration with PowerChina and offers attaching options to investors.